Pulse Biosciences, Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.07M0.25M0.45M0.98M0.11M1.42M0.70M
Gross Profit -0.55M-11.24M
Operating items
Research & Development 24.96M26.44M28.64M20.84M27.80M32.34M
Selling, General & Administrative 17.14M16.27M19.07M13.96M15.78M23.92M
Other Operating Expenses 5.86M7.26M16.72M23.96M
Operating Expenses 47.95M49.97M64.43M58.76M43.57M56.26M
Operating Income -47.95M-49.97M-63.01M-58.06M-43.57M-56.26M
EBIT -47.95M-49.97M-63.01M-58.06M-43.57M-56.26M
Non-operating items
Interest & Investment Income 0.98M0.11M-0.65M-0.45M1.36M2.67M
Non Operating Income 0.98M0.11M-0.65M-0.45M1.36M2.67M
Net income details
EBT -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Profit After Tax -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Income from Continuing Operations -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Consolidated Net Income -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Income towards Parent Company -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Net Income towards Common Stockholders -46.97M-49.85M-63.66M-58.51M-42.21M-53.59M
Additional items
EPS (Basic) -2.26-2.14-2.28-1.72-0.85-0.92
Shares Outstanding (Weighted Average) 20.79M25.34M29.63M37.23M54.99M67.27M
EBITDA -46.97M-49.86M-63.66M-58.51M-42.21M-53.59M
Shares Outstanding 25.55M29.72M37.23M55.14M65.93M